Latest long-term debt for EARS: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for EARS is $0 as of December 2023. That compares with $340K in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Auris Medical Holding's historical trend and sector peers before judging valuation or financial health.
Over the past year, EARS's long-term debt moved from $340K to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Auris Medical Holding's operating scale or balance-sheet position.
A long-term debt figure of $0 for EARS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting EARS's long-term debt ($0), review year-over-year change from $340K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Auris Medical Holding's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.